U.S. pharma giant copyright scrapped two experimental weight loss drugs very last 12 months—a the moment-day by day tablet, lotiglipron, as a result of elevated liver enzymes in addition to a 2 times-each day capsule, danuglipron, resulting from robust side effects—but CEO Albert Bourla has said the company is decided to “Perform and acquire�